Detalhe da pesquisa
1.
Response to therapy of papillary thyroid cancer of known BRAF status.
Clin Endocrinol (Oxf)
; 87(6): 815-824, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28718951
2.
A Significance of Concomitant BRAFV600E and TERT Mutations in Polish Patients with Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Based on 430 Cases.
Thyroid
; 32(11): 1372-1381, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35950639
3.
Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma.
Cancers (Basel)
; 13(3)2021 Jan 26.
Artigo
Inglês
| MEDLINE | ID: mdl-33530461
4.
Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?
J Clin Med
; 10(11)2021 May 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34072690
5.
Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?
Cancers (Basel)
; 12(2)2020 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32059462
6.
Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course.
Cancers (Basel)
; 11(11)2019 Nov 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31703344
7.
Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer.
Endocrinology
; 160(10): 2328-2338, 2019 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31305897
8.
The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.
PLoS One
; 13(10): e0204668, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30273371
9.
The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence.
PLoS One
; 11(4): e0153242, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27078258